Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
01 1Cayman Pharma s.r.o
02 1Gentec Pharmaceutical Group
03 1Chirogate International
04 1EUROAPI
05 1Transo-Pharm USA LLC
06 1LGM Pharma
07 1Century Pharmaceuticals
08 1Capital Farma
09 1ASAHI GLASS CO LTD
10 1Aspen Biopharma Labs
11 1CHEMO
12 1Dr Pradeep Reddy’s Laboratories Private Limited
13 1Everlight Chemical
14 1Guangdong Raffles PharmaTech Co Ltd
15 1Guangzhou Tosun Pharmaceutical
16 1MSN Laboratories
17 1Monvi Labs
18 1Shenzhen HwaGen Pharmaceutical
19 1Yangtze River Pharmaceutical Group
20 1Yonsung Fine Chemicals
21 1Zhejiang Ausun Pharmaceutical
22 1Zhejiang Tiantai Pharmaceutical
23 1Zhejiang Tianyu Pharmaceutical Co., Ltd
01 7China
02 1Czech Republic
03 1France
04 5India
05 1Japan
06 1South Korea
07 3Spain
08 2Taiwan
09 2U.S.A
01 6Active
02 17Blank
01 23Blank
01 1218MF10584
02 1303MF10019
03 1304MF10024
04 20Blank
01 1WC-0349
02 22Blank
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-07-15
Pay. Date : 2021-04-06
DMF Number : 35765
Submission : 2021-04-12
Status : Active
Type : II
Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33632
Submission : 2019-04-11
Status : Active
Type : II
Registration Number : 303MF10019
Registrant's Address : No. 2, Shih 4th Rd. , Yangmei Dist. , Taoyuan City 326013, Taiwan
Initial Date of Registration : 2021-01-26
Latest Date of Registration : --
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24400
Submission : 2010-11-28
Status : Active
Type : II
Registration Number : 218MF10584
Registrant's Address : 1-5-1 Marunouchi, Chiyoda-ku, Tokyo
Initial Date of Registration : 2006-06-22
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39505
Submission : 2024-02-06
Status : Active
Type : II
NDC Package Code : 76397-013
Start Marketing Date : 2020-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
We have 23 companies offering Tafluprost
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?